Single Entry
Stem Cell Transplantation Successfully Reverses Ra by psoriasis4
�A recent study by Scripps Research Institute scientists offers good news for families of children afflicted with the rare genetic disorder, cystinosis. In research that holds out hope for one day developing a potential therapy to treat the fatal disorder, the study shows that the genetic defect in mice can be corrected with stem cell transplantation.
“After meeting the children who suffer from this disease, like an 18-year-old who has already had three kidney transplants, and the families who are desperately searching for help, our team is committed to moving toward a cure for cystinosis, a lysosomal storage disorder,” says principal investigator Stephanie Cherqui, assistant professor in the Department of Molecular and Experimental Medicine. “This study is an important step toward that goal.”
In the study, which is published in the September 17, 2009 print edition of the journal Blood, the Scripps Research team used bone marrow stem cell transplantation to address symptoms of cystinosis in a mouse model. The procedure virtually halted the cystine accumulation responsible for the disease and the cascade of cell death that follows.
Cystine is a byproduct of the break down of cellular components the body no longer needs in the cell’s “housekeeping” organelles, called lysosomes. Normally, cystine is shunted out of cells, but in cystinosis a gene defect of the lysosomal cystine transporter causes it to build up, forming crystals that are especially damaging to the kidneys and eyes.
A Rare But Devastating Disease
While cystinosis is rare - affecting an estimated 500 people in the United States and 2,000 worldwide - it is devastating. Three types of cystinosis have been described based on the age at diagnosis and the amount of cystine in cells: infantile onset, adolescent onset, and adult onset. Children as young as six months can begin to suffer renal dysfunction, which grows progressively worse with time. Other symptoms include diabetes, muscular disease, neurological dysfunction, and retinopathy. Infantile onset is the most common, as well as the most severe, form of the disease.
The only available drug to treat cystinosis, cysteamine, while slowing the progression of kidney degradation, does not prevent it, and end-stage kidney failure is inevitable.
“Cysteamine must be given every six hours, so children have to be woken up each night to take this drug, which has unpleasant side effects, and many others to treat various symptoms,” Cherqui says. “So although there is treatment, it is difficult treatment that does not cure the disease.”
“Surprised and Encouraged”
In the new study, the researchers found that transplanted bone marrow stem cells carrying the normal lysosomal cystine transporter gene abundantly engrafted into every tissue of the experimental mice. This led to an average drop in cystine levels of about 80 percent in every organ. In addition to preventing kidney dysfunction, there was less deposition of cystine crystals in the cornea, less bone demineralization, and an improvement in motor function.
“The results really surprised and encouraged us,” says Cherqui, who as a doctoral student in France in 1998 helped discover the gene involved in cystinosis. “Because the defect is present in every cell of the body, we did not expect a bone marrow stem cell transplant to be so widespread and effective.”
Cherqui,psoriasis, who generated the mouse model in 2000 that is currently used to study cystinosis, says that adult bone marrow stem cell therapy is particularly well suited as a potential treatment for cystinosis because these cells target all types of tissues. In addition, stem cells reside in the bone marrow for the duration of a patient’s life, becoming active as needed, a particular benefit for a progressive disease like cystinosis.
The work of Cherqui and her colleagues may have wider applications for other genetic diseases, providing proof of principle that adult stem cell transplants may be successful in humans for genetic diseases with systemic defects, especially those of a progressive nature.
Cherqui expects to spend the next several years analyzing the safety of genetically modified autologous (obtained from the same individual) bone marrow transplants in the cystinosis mouse and other models before moving on to human clinical trials.
In addition to Cherqui, authors of the study “Successful treatment of the murine model of cystinosis using bone marrow cell transplantation” include first author Kimberly Syres of Scripps Research; Frank Harrison, Matthew Tadlock, and Daniel R. Salomon of Scripps Research; James V. Jester and Jennifer Simpson of the University of California, Irvine; and Subhojit Roy of the University of California, San Diego.
This work was funded by the Cystinosis Research Foundation.
Source:
Keith McKeown
Scripps Research Institute
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Genetics
>
Categories A-B
Abortion
Acid Reflux / GERD
ADHD
Aid / Disasters
Alcohol / Addiction / Illegal Drugs
Allergy
Alternative Medicine
Alzheimer’s / Dementia
Anxiety / Stress
Arthritis / Rheumatology
Asbestos / Mesothelioma
Asthma Autism
Back Pain
Bio-terrorism / Terrorism
Biology / Biochemistry
Bipolar
Bird Flu / Avian Flu
Blood / Hematology
Body Aches
Bones / Orthopaedics
Breast Cancer
>
Categories C-D
Cancer / Oncology
Cardiovascular / Cardiology
Caregivers / Homecare
Cervical Cancer / HPV Vaccine
Cholesterol
CJD / vCJD / Mad Cow Disease
Cleft Palate
Clinical Trials / Drug Trials
Colorectal Cancer
Complementary Medicine
Compliance
Conferences
COPD
Cosmetic Medicine
Crohn’s
Cystic Fibrosis
Dentistry
Depression
Dermatology
Diabetes Dyslexia
>
Categories E-G
Ear, Nose and Throat
Eating Disorders
Eczema / Psoriasis
Endocrinology
Epilepsy
Erectile Dysfunction
Eye Health / Blindness
Fertility
Fibromyalgia
Flu / Cold / SARS
GastroIntestinal / Gastroenterology
Genetics Gout
Gynecology
>
Categories H-L
Headache / Migraine
Health Insurance / Medical Insurance
Hearing / Deafness
Heart Disease
HIV / AIDS
Huntingtons Disease
Hypertension
Immune System / Vaccines
Infectious Diseases
Irritable-Bowel Syndrome
IT / Internet / E-mail
Litigation
Liver Disease / Hepatitis
Lung Cancer
Lupus
Lymphology / Lymphedema
Lymphoma / Leukemia
>
Categories M-O
Medical Devices / Diagnostics
Medical Malpractice
Medical Practice Management
Medical Students / Training
Medicare / Medicaid / SCHIP
Melanoma / Skin Cancer
Men’s Health
Menopause
Mental Health
MRI / PET / Ultrasound
MRSA / Drug Resistance
Multiple Sclerosis
Muscular Dystrophy / ALS
Myeloma
Neurology / Neuroscience
Nursing / Midwifery
Nutrition / Diet
Obesity / Weight Loss / Fitness
Ovarian Cancer
>
Categories P-R
Pain / Anesthetics
Palliative Care / Hospice Care
Pancreatic Cancer
Parkinson’s Disease
Pediatrics / Children’s Health
Pharma / Biotech Industry
Pharmacy / Pharmacists
Plastic Surgery
Pregnancy / Obstetrics
Premature Ejaculation
Preventive Medicine
Primary Care / General Practice
Prostate / Prostate Cancer
Psychology / Psychiatry
Public Health
Radiology / Nuclear Medicine
Regulatory Affairs / Drug Approvals
Rehabilitation / Physical Therapy
Respiratory
>
Categories S-Z
Schizophrenia
Seniors / Aging
Sexual Health / STDs
Sleep / Sleep Disorders
Smoking / Quit Smoking
Sports Medicine / Fitness
Statins
Stem Cell Research
Stroke
Swine Flu
Transplants / Organ Donations
Tropical Diseases
Tuberculosis
Urology / Nephrology
Vascular
Veterans / Ex-Servicemen
Veterinary
Viruses / Bacteria
Water - Air Quality / Agriculture
Women’s Health
View full category list
Stretching on the Move
You may think of static poses when you think of stretching. But more and more, people are incorporating dynamic stretches into their warmup. Dynamic stretching involves moving parts of your body, gradually increasing range and speed.
more videos are available in our health videos section.
swine flu nutrition cancer cardiovascular diabetes hiv obesity pediatrics neurology dermatology urology pregnancy psychology medicare infectious diseases alcohol breast cancer women’s health asthma gastrointestinal alzheimer’s stem cell research prostate bones pain sexual health smoking eye health sleep sports medicine multiple sclerosis health insurance medical devices hypertension dentistry biology genetics depression it arthritis autism pharma industry fertility abortion liver disease mrsa seniors nursing anxiety allergy
Recommend reading articles:
Leave Your Reply Below